Peptides/CJC-1295 + Ipamorelin
CJC-1295 + Ipamorelin
Growth Hormonemoderate evidence

CJC-1295 + Ipamorelin

Synergistic GH release for recovery and longevity

CJC-1295 is a growth hormone-releasing hormone (GHRH) analog, often combined with Ipamorelin (a growth hormone secretagogue). Together, they stimulate pulsatile growth hormone release while minimizing cortisol and prolactin spikes.

⚙️ Mechanism of Action

CJC-1295 extends the half-life of endogenous GHRH signaling via Drug Affinity Complex (DAC) technology. Ipamorelin selectively activates ghrelin receptors in the pituitary. The combination produces amplified, physiologic GH pulses.

Benefits

  • Increased lean muscle mass
  • Enhanced fat metabolism
  • Improved sleep quality and depth
  • Faster recovery from exercise
  • Improved skin elasticity and collagen synthesis

⚠️ Risks & Considerations

  • Water retention and joint stiffness
  • Potential insulin resistance with prolonged use
  • Headaches and flushing (dose-dependent)
  • Not FDA-approved for anti-aging use

Ready to Start?

$59.99

Purchase research-grade CJC-1295 + Ipamorelin from a trusted supplier.

Purchase CJC-1295 + Ipamorelin

Affiliate link — we may earn a commission at no extra cost to you.

Quick Facts

💉
Dosing Range
CJC-1295: 100–300 mcg + Ipamorelin: 100–300 mcg, 1–3x daily
⏱️
Half-Life
CJC-1295: ~6–8 days (with DAC), Ipamorelin: ~2 hours
🔄
Typical Cycle
8–12 weeks on, 4 weeks off
Time to Effect
1–2 weeks for sleep; 4–8 weeks for body composition
Administration Routes
Subcutaneous injection
🧬PeptidesAgent

⚠️ For informational purposes only. Not medical advice. Always consult a qualified healthcare provider before using any peptide or supplement.

© 2026 PeptidesAgent·Admin

PeptidesAgent

Usually replies instantly

Hi there! 👋

Ask me anything about peptides, dosing protocols, or stacks.

For research purposes only · Not medical advice